Literature DB >> 5027972

A toxicologic comparison of the potency and activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in mice and rats.

G R Thompson, R E Larson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5027972     DOI： 10.1016/0041-008x(72)90160-3

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  5 in total

1.  Intensive chemotherapy with autologous bone marrow rescue for recurrent malignant gliomas.

Authors:  K Nomura; T Watanabe; O Nakamura; M Ohira; S Shibui; K Takakura; Y Miki
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

2.  Distribution of Bratton-Marshall-positive material in mice following intravenous injections of nitrosoureas.

Authors:  P Kari; W R McConnell; J M Finkel; D L Hill
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Reduction of glutathione levels in livers of mice treated with N,N'-bis (2-chloroethyl)-N-nitrosourea.

Authors:  W R McConnell; P Kari; D L Hill
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  BCNU-induced quantitative and qualitative changes in hepatic cytochrome P-450 can be correlated with cholestasis.

Authors:  J C Stolzenbach; R E Larson
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  DTI-015 produces cures in T9 gliosarcoma.

Authors:  Dennis Pietronigro; Frank Drnovsky; Humberto Cravioto; Joseph Ransohoff
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.